# Medkart Pharmacy Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medkart-pharmacy-pvt

- Industry: Pharmaceuticals
- Headquarters: Ahmedabad, India
- Website: www.medkart.in
- Total disclosed funding: $0.5M
- Latest round: Series A (Nov 23, 2021)
- Investors on record: 2

## About

Based in India, Medkart Pharmacy Pvt Ltd is an online pharmacy that specializes in providing a variety of generic and branded medicines, enhancing access to affordable healthcare solutions.Founded in 2014 and headquartered in Ahmedabad, India, Medkart Pharmacy Pvt Ltd offers an online platform for purchasing pharmaceuticals. The company was established by Ankur Agarwal, who brings experience from previous ventures. Medkart raised INR 40 million in a Series A funding round on November 23, 2021, co-led by Alkemi Growth Capital and Insitor Partners, which marks the total amount raised by the company as INR 40 million.Medkart Pharmacy specializes in the online sale of generic and branded medicines, providing a comprehensive platform for purchasing pharmaceuticals. The core offerings include a wide range of medicines, including over-the-counter products, prescription medications, and homeopathic and ayurvedic remedies. These products are sourced directly from WHO-GMP certified manufacturers, ensuring authenticity and compliance with industry standards. Medkart serves a diverse customer base, including individual consumers seeking affordable healthcare solutions, patients with chronic conditions, and those looking for alternative treatments. The company primarily operates in the Indian market, leveraging a robust online platform to facilitate seamless access to medications across over 35,000 pin codes, making it a key player in the healthcare retail sector.In the most recent fiscal year of 2023, Medkart Pharmacy reported a revenue of INR 4,440,162.50 and an EBITDA of INR -700,747.50. The revenue model for Medkart Pharmacy revolves around direct-to-consumer sales, with transactions occurring through their user-friendly website and mobile application. Customers can place orders for medications, utilizing features such as prescription uploads or product searches to facilitate their purchases. Pricing structures vary across products, with significant discounts commonly reaching up to 85%, making the platform attractive for cost-conscious consumers. Medkart's offerings include both generic medications and branded products, ensuring a diverse selection that caters to various healthcare needs. The company has established a strong presence in the online pharmacy space, focusing on affordability and accessibility as key drivers of its business.Medkart Pharmacy plans to expand its product offerings and enhance its online platform to improve user experience. Specific details on upcoming products and their release dates are not disclosed at this time. The company aims to further penetrate the Indian market while exploring potential expansion into neighboring regions. The recent Series A funding of INR 40 million will be utilized to support these growth initiatives and enhance operational capacity.

## Funding rounds

- Series A, Nov 23, 2021, $0.5M — Insitor Partners, Alkemi Growth Capital

## Investors

- Insitor Partners (https://capitalatlas.ai/funds/insitor-partners) — Series A
- Alkemi Growth Capital (https://capitalatlas.ai/funds/alkemi-growth-capital) — Series A